A Clinical Study to Evaluate the Efficacy, Safety, and Tolerability of TERN-601 in Adults With Overweight or Obesity
Public ClinicalTrials.gov record NCT06854952. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2 Study to Evaluate the Efficacy, Safety, and Tolerability of TERN-601 in Adults With Overweight or Obesity
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a Phase 2a multicenter, randomized, double-blind, placebo-controlled clinical trial studying the efficacy, safety, and tolerability of orally administered TERN-601 in adults with overweight or obesity.
Study identification
- NCT ID
- NCT06854952
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 167 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 7, 2025 (Actual)
- Primary completion
- Aug 19, 2025 (Actual)
- Completion
- Sep 19, 2025 (Actual)
- Last update posted
- Aug 10, 2026
2025
United States locations
- U.S. sites
- 17
- U.S. states
- 14
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| FALCON Research Site | Birmingham | Alabama | 35294 | — |
| FALCON Research Site | Homewood | Alabama | 35209 | — |
| FALCON Research Site | Tucson | Arizona | 85712 | — |
| FALCON Research Site | Spring Valley | California | 91978 | — |
| FALCON Research Site | Port Orange | Florida | 32127 | — |
| FALCON Research Site | Louisville | Kentucky | 40213 | — |
| FALCON Research Site | Marrero | Louisiana | 70072 | — |
| FALCON Research Site | Boston | Massachusetts | 02114 | — |
| FALCON Research Site | Rochester | Minnesota | 55905 | — |
| FALCON Research Site | City of Saint Peters | Missouri | 63303 | — |
| FALCON Research Site | Beachwood | Ohio | 44122 | — |
| FALCON Research Site | Medford | Oregon | 97504 | — |
| FALCON Research Site | Dallas | Texas | 75230 | — |
| FALCON Research Site | Houston | Texas | 77079 | — |
| FALCON Research Site | San Antonio | Texas | 78229 | — |
| FALCON Research Site | St. George | Utah | 84790 | — |
| FALCON Research Site | Arlington | Virginia | 22206 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06854952, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 10, 2026 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT06854952 live on ClinicalTrials.gov.